In a recently filed product liability lawsuit over Allergan’s Natrelle Silicone breast implants, a Virgina woman indicates that the macrotextured implants caused her to develop a rare form of cancer, known as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).

The complaint (PDF) was filed last week in New Jersey Superior Court, but Michele Rea and her husband, Carl, indicating that Allergan concealed the potential ALCL cancer risk with Natrelle breast implants.

Even after the FDA warning, Rea indicates that Allergan failed to adequately warn patients or the medical community about the risks of its implants.

In June 2017, a study published in the medical journal Plastic and Reconstructive Surgery suggested that certain textured breast implants may increase the risk of anaplastic large cell lymphoma anywhere from 10 to 14 times, when compared to smooth breast implants.

The FDA has received 359 medical device reports (MDRs) of breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL. Nine of these women died, and many are filing lawsuits.